Sun Pharma launched Gleevec generic on February 1, 2016 with 180-day exclusivity and it has already captured around 40-50 percent market share. ...http://www.moneycontrol.com/news/result-poll/sun-pharma-q4-profit-seen113-gleevec-may-drive-us-sales_6759761.html
Email this Print Sun Pharma stock surged 5.8 per cent today after its US subsidiary Taro Pharmaceutical Industries reported strong sales growth... ...http://smartinvestor.business-standard.com/market/Marketnews-386516-Marketnewsdet-Sun_Pharma_stock_up_58_over_subsidiary_Taros_strong_quarterly_result.htm
Future Market Insights has announced the addition of the Blood Cancer Treatment Market Treatment Market: Global Industry Analysis and Opportunity... ...http://pressreleaseping.com/blood-cancer-treatment-market-growth-trends-and-value-chain-2016-2026
Novartis (NYSE:NVS) Intraday Stock Chart Today : Saturday 21 May 2016 By Kejal Vyas BOGOTÁ -- Colombia's government will override... ...http://in.advfn.com/p.php?pid=nmona&article=71541552
From the Wires - First data from two treatment-free remission (TFR) studies of Ph+ CML patients treated with Tasigna® both in front-line and... ...http://in.sys-con.com/node/3820419
For Buying Imatinib & Gleevec Online...
Imatinib mesylate 400mg tablets is a...